Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-038250
Filing Date
2024-03-29
Accepted
2024-03-28 18:15:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A coya_defa14a_nanda_2.htm DEFA14A 25137
2 GRAPHIC img125985699_0.jpg GRAPHIC 268412
3 GRAPHIC img125985699_1.jpg GRAPHIC 256791
  Complete submission text file 0000950170-24-038250.txt   749640
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41583 | Film No.: 24801053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)